Evercore ISI Downgrades Crinetics (CRNX) to In Line

Evercore ISI analyst Gavin Clark-Gartner downgraded Crinetics (NASDAQ: CRNX) from Outperform to In Line with a price target of $85.00 (from $88.00).

For an analyst ratings summary and ratings history on Crinetics click here. For more ratings news on Crinetics click here.

Shares of Crinetics closed at $83.53 yesterday.

You May Also Be Interested In

• Securitize Corp (SECZ) PT Raised to $12 at StoneX on 'Innovation Exemption'
• Discovery Silver Corp (DSV:CN) (DSVSF) PT Raised to Cdn$15 at BMO Capital
• HubSpot Inc (HUBS) PT Raised to $290 at UBS, Stock Expected to Be Execution-Driven Near-Term